Amgen Director of Business Development Salaries in Los Angeles
The average Amgen Director of Business Development in Los Angeles earns $283,000 annually, which includes a base salary of $193,000 with a $90,000 bonus. This total compensation is $116,698 more than the US average for a Director of Business Development.
In Los Angeles, The Business Development Department at Amgen earns $782 more on average than the Finance Department. Comparably data has a total of 1 salary record from Amgen Directors of Business Development.
Last updated 2 months ago.
- $193,000
- avg. base
- $90,000
- avg. bonus
- 50K-100K
- equity range
Director of Business Development Salaries at Amgen
In Los Angeles, Directors of Business Development earn $155,352 more than Business Development Managers.
Compensation at Amgen by Department
In Los Angeles, The Business Development Department averages $782 more than the Finance Department, and $5,526 less than the IT Department
Average Equity for Director of Business Development at Amgen
In Los Angeles, the average Director of Business Development at Amgen receives $100K of stock in equity.
Recent Director of Business Development Salaries at Amgen
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to Amgen reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to Amgen reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at Amgen Rate Their Compensation
The majority of Directors of Business Development at Amgen believe they're compensated fairly. 89% of Directors of Business Development at Amgen say they receive annual bonuses, and the vast majority (82%) are satisfied with their benefits. See more compensation ratings at Amgen
